Doctors Without Borders (MSF) has called for a drastic reduction in the price of a key medication used to prevent HIV infection, as the International AIDS Conference begins in Rio de Janeiro on ...
The CDC will not renew a federal grant that provided the Aliveness Project roughly $450,000 a year for HIV testing, PrEP ...
Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir. The New Jersey pharma is ...
The health agency will route HIV prevention grants through state and local health departments instead of directly funding ...
HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...
The Trump administration will not renew direct federal funding of community-based organizations that work on HIV prevention, ...
The Trump administration’s disruptions to a global AIDS relief program have forced organizations to close clinics, lay off ...
Local production would strengthen healthcare security across the continent and reduce reliance on imported medicines.
Avantor (NYSE:AVTR), through its NuSil brand, has expanded its collaboration with the Population Council. The partnership focuses on supporting the development of a three-month dapivirine vaginal ring ...
In June, the US Food and Drug Administration approved a new drug that could transform HIV prevention. People at risk of HIV can get an injection of lenacapavir every six months and be almost ...
"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.